Yousef Zakharia/mayoclinic.org
Feb 12, 2025, 07:01
Yousef Zakharia: IIT in recur refractory RCC
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa, shared his recent articles on X:
“Thrilled to share 2 recent papers related to our IIT in recur refractory RCC, 1st one in Clinical Cancer Research.”
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear Cell Renal Cell Carcinoma.
Authors: Yousef Zakharia, et al.
“and the other 1 Cancer Treat Res Commun doi:
Many yrs of work, many collaborators.”
Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential.
Authors: Aseel O Rataan, et al.
and the other one in…”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 12, 2025, 13:37
Mar 12, 2025, 13:30
Mar 12, 2025, 13:13
Mar 12, 2025, 13:13
Mar 12, 2025, 13:02
Mar 12, 2025, 12:59
Mar 12, 2025, 12:51
Mar 12, 2025, 12:37